MKI The Medipattern Corp.

The Medipattern Corporation ("Medipattern") (TSX VENTURE: MKI), a pioneer in the development of medical imaging software solutions that help medical practitioners in better understanding lesions and critical anatomy, and TomTec Imaging Systems GmbH, a worldwide leader for 2D-, 3D- and 4D- solutions in the area of medical ultrasound, are pleased to announce that they have signed a teaming agreement for Medipattern's B-CAD® breast ultrasound imaging computer aided detection (CAD) product. TomTec has integrated B-CAD into its Image-Arena™ Platform Suite. B-CAD will make its debut in Image-Arena during the upcoming European Congress of Radiology in Vienna, Austria March 3-7, 2011.

"TomTec and Medipattern have the skill and knowledge to bring analysis of breast lesions to the forefront," commented Ellen Mendelson, MD FACR, who co-authored the book The Practice of Breast Ultrasound: Techniques, Findings and Differential Diagnosis with Prof. Dr. Helmut Madjar. "BI-RADS® based B-CAD facilitates characterization of breast lesions imaged with ultrasound. Globally, ultrasound is the leading diagnostic modality used for assessing breast masses, yet understanding ultrasound images can be difficult. B-CAD is a great tool for analyzing features of masses and educating practitioners."

"TomTec is a leader in Ultrasound applications and image analysis. In our initiative to expand our offerings in general radiology, TomTec decided to make a concentrated focus for breast imaging," commented Frank Schlau CMO of TomTec Imaging Systems GmbH. "We naturally sought out a working relationship with Medipattern as a pillar in our strategy. Medipattern has top marks in quality, development excellence and clinical understanding. We look forward to marketing our new breast centric application to our partners and customers worldwide."

"Medipattern's key strength is in analysis of critical anatomy within a particular organ for example lesions within a breast. TomTec has an array of applications which they combine into specialized suites bundled for their OEM customers. The cooperation with TomTec will enable us to offer our B-CAD advanced application together with a large suite of products to TomTec's well established sales channels," commented Jeff Collins, President and CEO of The Medipattern Corporation. "The teaming agreement combines each of our company's strengths to lead the market with an enriched suite dedicated to breast care."

About The Medipattern Corporation:

Medipattern® is a pioneer in the development of imaging software solutions that help medical practitioners to better understand lesions and critical anatomy. Our first-to-market, award-winning B-CAD® advances breast ultrasound computer aided detection (CAD) by streamlining workflow and organizing information into a comprehensive patient record. Medipattern uses its Cadenza™ CAD Technology to power the digital conversion in medical communications. B-CAD automatically creates fully digital standardized worksheets and reports that make every practice more efficient, productive and ultimately more effective. For more information, please visit the Company's website at: www.medipattern.com.

About TomTec Imaging Systems, GmbH:

TomTec Imaging Systems GmbH is the worldwide leader for 2D-, 3D- and 4D- solutions in the area of medical ultrasound and aims to be a worldwide leader in medical imaging software solutions. Since 1990, the company has developed as a pioneer in 3D/4D ultrasound, Stress Echo and Image Management technology. By offering "Add On" and OEM (Original Equipment Manufacturer) solutions to all major ultrasound companies, TomTec has reached a leading position in its market. TomTec holds a leading position in driving innovations in the field of diagnostic medical imaging applications and also offers products for the PACS market. TomTec integrates its technology for routine clinical use into the medical device manufacturing products of our partners. The product line encompasses a wide range of 2D and 3D/4D technology for visualization, analysis, quantification and information-processing as well as for management of multimodality image data. TomTec's products are applicable to the fields of adult and pediatric cardiology as well as obstetrics, gynecology, radiology, and vascular diagnostics.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential", and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

B-CAD® and Medipattern® are a registered mark of The Medipattern Corporation.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts: The Medipattern Corporation Jeff Collins CEO (416) 744-0009 ext. 224 jcollins@medipattern.com Spinnaker Capital Markets Inc. Kevin O'Connor (416) 962-3300 ext. 226 ko@spinnakercmi.com

The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jun 2024 to Jul 2024

The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jul 2023 to Jul 2024